0
IBM’s Thomas J. Watson Research Center and researchers at the University of California, Davis, begin collaborative development of an innovative system for Total Hip Arthroplasty (THA). Their goal is to create a robotic surgical system that will redefine precision in joint replacement procedures.
0
The ROBODOC® Surgical System makes medical history. By assisting a surgeon in a THA procedure, the system becomes the first of its kind to be used on humans. This breakthrough leads to rapid development of three-dimensional image-directed, preoperative planning and computer-guided robotic surgery. That same year the ROBODOC® development team receives the prestigious Computerworld Smithsonian Award for Innovation in the Arts and Sciences for Medicine.
0

Commercialization of the ROBODOC®Surgical System begins in Europe while the Company continues to push the cutting edge of robotic technology for orthopedics forward. Among ROBODOC® advances are Total Hip Arthroplasty with cementless implant, Total Knee Arthroplasty*, and Revision Total Hip Arthroplasty.

* TKA and RTHA not available for sale in U.S.

Mid0
A partnership with Curexo Inc. of Korea enables ROBODOC® to complete clinical studies at three major United States hospitals and proceed with the next level of technical development.
August0
The ROBODOC® Surgical System receives 510(k) clearance from the United States Food and Drug Administration (FDA) for Total Hip Arthroplasty procedures. It is still the only active robotic system cleared by the U.S. FDA for orthopedic surgery.
May0
The first commercial system established at Sutter General Hospital in Sacramento, CA.
0

28,000 and counting. The ROBODOC®System has been used in more than 28,000 joint replacements worldwide.*

* System not available for total knee replacements in the U.S.

0
Curexo Technology becomes THINK Surgical, Inc., committed to developing and commercializing advanced computer-assisted systems for leading-edge joint replacements.
ROBODOC® EncoreTM Surgical System receives 510(k) clearance from the United States Food and Drug Administration (FDA) for Total Hip Arthroplasty procedures.
August 2014: TSolution One® Surgical System receives 510(k) clearance from the United States Food and Drug Administration (FDA) for Total Hip Arthroplasty procedures.
0
September 2015: TSolution One® Surgical System receives CE mark for Total Hip Arthroplasty procedures.
October 2015: TSolution One® Surgical System receives 510(k) clearance from the United States Food and Drug Administration (FDA) for Total Hip Arthroplasty and Cup Placement procedures.
0
February 2016: The TSolution One® Surgical System is FDA cleared for Femoral Canal and Acetabular Cup Preparation for THA, with limited reuse of cutter motor and bearing sleeve and improved graphic user interface.
November 2016: The 1989 ROBODOC® prototype, the TSolution One® core technology, was added to the Smithsonian National Museum of American History as part of their Science and Medicine Collection.